S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer

doi:10.3748/wjg.v20.i38.13987

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 38

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6697)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

416

WORD

185

HTML

3152

Figures (1-1)

248

Tables (1-2)

216

Sum=4217

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1172

Download

1308

Sum=2480

Oct 14, 2014 (publication date) through Jan 24, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Oct 14, 2014; 20(38): 13987-13992
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13987

Table 1 Characteristics of the patients n (%)

Characteristic	Number of patients
Age (yr)
Range	50-69
Median	55
Gender
Female	17 (53.12)
Male	15 (46.88)
Karnofsky performance status
100	20 (62.5)

Citation: Ke QH, Zhou SQ, Yang JY, Du W, Liang G, Lei Y, Luo F. S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer. World J Gastroenterol 2014; 20(38): 13987-13992
URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13987.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13987